Vyepti + patent expiry date?

Vyepti is the brand name for eptinezumab-jjmr, a CGRP monoclonal antibody. Patent expiry for Vyepti depends on the jurisdiction and on multiple patent families (e.g., composition of matter, methods of use, manufacturing/formulation). There isn’t a single universal “expiry date”.

If you’d like, I can look up the current patent status and give you a clear list of:
- US patents (composition of matter, methods of use, etc.) with their expiry dates
- EU patents and expiry dates
- Any other regions you care about
- Also note regulatory data exclusivity (which can delay biosimilar entry even after patents expire)

Questions to tailor the answer:
1) Which jurisdictions do you care about (US, EU, or worldwide)?
2) Do you want:
- composition-of-matter patents only, or also use/matérielle/formulation patents?
- regulatory data exclusivity in addition to patent dates?

If you’d like, I can fetch the latest patent data from public databases (USPTO, EPO, Google Patents) and summarize with patent family names, numbers, and expiry dates.